MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cadrenal Therapeutics (CVKD) Ownership - Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

Profile

Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.64M
P/E Ratio
N/A
Total Cash
3.86M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.65
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CVKD
Capitalization
19.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.86M
Total Cash/Share
1.65
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.74M
P/B Ratio
7.18
Cash Flow
N/A
Earnings
-8.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.06K
Current Ratio
3.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-328.18
Shares Held By Institutions
2.14M
Shares Outstanding - Current
2.34M
Total Liabilities
1.35M
Total Volume MTD
N/A
Value
N/A
Gain YTD
23.894
View a ticker or compare two or three
CVKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CVKD showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com